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The aim of this study was to determine predictive factors for pregnancy and assess the
cumulative pregnancy rate (CPR) and live birth rate (CLBR) in subfertile couples
undergoing timed intercourse (TI) using ultrasound. This retrospective cohort study
included 285 women (854 cycles) who started TI with ultrasound between January
2017 and October 2019. The overall clinical pregnancy rate was 28.1% (80/285) per
couple and 9.4% (80/854) per cycle. Pregnant women had a higher body mass index
(BMI), higher percentage of irregular menstrual cycles, a shorter duration of subfertility,
lower serum follicle-stimulating hormone levels, and higher anti-Müllerian hormone levels
than non-pregnant women. A longer duration of subfertility (≥24 months vs. <12 months;
odds ratio: 0.193; 95% confidence interval: 0.043-0.859) and endometriosis (vs. ovulatory
factors; odds ratio: 0.282; 95% confidence interval: 0.106-0.746) as causes of subfertility
were unfavorable factors that independently affected clinical pregnancy. In subgroup
analysis, old age ≥ 35 years [vs. < 35 years; odds ratio: 0.279; 95% confidence interval:
0.083-0.938), a longer duration of infertility ≥24 months (vs. <24 months; odds ratio:
0.182; 95% confidence interval: 0.036-0.913) and a higher BMI ≥ 25 kg/m2(vs. >25 kg/
m2; odds ratio: 3.202; 95% confidence interval: 1.020-10.046) in couples with ovulatory
factor and a longer duration of infertility ≥24 months (vs. <24 months; odds ratio: 0.185;
95% confidence interval: 0.042-0.819) in couples with non-ovulatory factors were
significant independent predictive factors for pregnancy. No significant differences were
found in the cycle characteristics between pregnant and non-pregnant women. The CPR
substantially increased during the first three cycles and significantly increased until the
sixth cycle. No significant increase was observed in the CPR after the sixth cycle. The
CLBRs substantially increased during the first three cycles and significantly increased until
the fourth cycle. No significant increase was observed in the CLBRs after the fifth cycle.
When comparing CPRs and CLBRs according to subfertile causes, CRPs wasn.org April 2021 | Volume 12 | Article 6508831
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Frontiers in Endocrinology | www.frontiersisignificantly different and CLBRs was different with borderline significance. Our findings
may indicate that women with a longer duration of subfertility or subfertility due to
endometriosis have poor outcomes during TI with ultrasound. Women who failed to
achieve conception by the fourth or fifth cycle of TI with ultrasound may be encouraged
to consider advancing to the next treatment strategy.Keywords: timed intercourse, ultrasonography, predictive factor, cumulative pregnancy rate, subfertile couplesINTRODUCTION
Approximately 85-90% of healthy young couples conceive within
1 year, most within 6 months (1, 2). Infertility therefore affects
approximately 10-15% of couples and represents a significant
part of clinical practice (3). A normal sperm can maintain the
ability to fertilize an egg for at least 3 and up to 5 days, but an
oocyte can be fertilized for about 12-24 hours after ovulation.
Consequently, virtually all pregnancies result from sexual
intercourse occurring sometime within the 6-day interval, the
fertile window, ending on the day of ovulation (4, 5). Therefore,
timed intercourse (TI) during this fertile window, is one of the
simple and commonly prescribed treatments for couples who
want to become pregnant.
However, even when intercourse is carefully timed, cycle
fecundity does not exceed approximately 35% in normally
fertile couples (4, 6). While continuing to attempt pregnancy
with TI, women should also consider age-related decline in
fertility over time (7). The anxiety of repeated unsuccessful
conceptions and pressures of timed coitus are stresses for both
partners that might also reduce the chances of pregnancy (8, 9).
Therefore, attempts using TI for a reasonable sustainable period
is important to avoid both over- and under-management for
couples who wish to become pregnant.
Previous studies on TI predicted ovulation by indirect indexes
such as calendar charting, tracking basal body temperature,
cervical secretion investigation, and urinary hormone
measurement, including the levels of luteinizing hormone (LH)
or estrogen.
Fertility awareness-based methods (FABMs) estimate the
fertile time by observing fertility signs such as cervical
secretions and basal body temperature or monitoring cycle
length (10). Those parameters have long been used because of
simplicity and non-invasiveness. However, they are difficult to
interpret and need an educational component for proper use (11,
12). A randomized study comparing cervical mucus monitoring
versus frequent intercourse found no benefit to the pregnancy
rate in the mucus monitoring group (13). Mobile fertility
tracking applications predict fertile days based on one or more
parameters of the FABMs. However, most applications were not
developed or sponsored by health care professionals and
assumed fertile windows regardless of average cycle length or
between-cycle variability. Therefore, there are concerns about
reliability and effectiveness (14, 15).
Urinary ovulation predictor kits that monitor LH and or
estrone-3-glucuronide (E1G) in urine are convenient, non-
invasive methods to detect ovulation. However, they do notn.org 2allow the prospective determination of the entire fertile window
(16, 17) and may present a relatively high number of false
negatives when peak LH concentrations are low or when the
LH surge duration is too short to be detected (18, 19). False-
positive test results also occur in approximately 7% of cycles (20).
In a systemic review, three randomized controlled trials showed
that urinary ovulation kits might increase pregnancy rates
compared with not using them (pooled RR: 1.36; 95% CI: 1.07-
1.73) (21). However, the quality of evidence was low to very low
with a very small number of total participants. New tests that
combine existing indirect indices using software applications or
detect new materials are being studied to increase the predictive
value (22–24); clinical usefulness is expected in the future.
The most direct method, laparoscopy, is technically difficult
to perform routinely. Another direct method is to detect the
maximum growth of dominant follicles close to ovulation and its
subsequent reduction in size by high-resolution transvaginal
ultrasonography (TVUS) (25). The time of ovulation can be
determined precisely through follicle monitoring using
ultrasound (26–29). Ultrasonography is recognized as a
reference test for ovulation detection and is used primarily in
assisted reproductive technology (ART) that requires a clear
fertility window (30). Although information on predictive factors
of conception, the cumulative pregnancy rate (CPR) and the
cumulative live birth rate (CLBR) in couples undergoing TI with
ultrasound may help decide when to advance to the next
treatment, few data are available. Our study aimed to
determine predictive factors for pregnancy and assess the CPR
and the CLBR in couples undergoing TI with ultrasound.MATERIALS AND METHODS
The medical records were retrieved from 285 couples who started
TI with ultrasound at the Severance Hospital Infertility Clinics
from January 2017 to October 2019. The inclusion criteria were
couples trying to conceive, and unable to conceive for more than
6 months of usual sexual intercourse. Women aged between 27
and 43 years were included. Only women with at least one patent
tube were included. Couples who currently received subfertility
treatments or those with severe male factor infertility including
azoospermia or severe oligoasthenoteratozoospermia (<10
million total motile sperm count or <2% strict normal
morphology) were excluded. Women without a heterosexual
partnership were excluded. Among all started cycles, the cycles
in which intercourse was missed and ovulation did not occur
were not included for the analysis. The duration of subfertilityApril 2021 | Volume 12 | Article 650883
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contraceptive activities until registration at the fertility center.
The menstrual cycle was considered regular if the cycle period
was between 24 and 38 days, with interval variation less than 20
days. Our study was approved by the Institutional Review Board
of Severance Hospital, Yonsei University College of Medicine
(No. 2020-0312).
Patients visited the clinic on the day 2 to 5 of the menstrual
cycle and had undergone medical and reproductive history
recording, serum hormone assays including follicle-stimulating
hormone (FSH), LH, estradiol (E2), anti-Müllerian hormone
(AMH), thyroid-stimulating hormone, prolactin, and baseline
TVUS. Hysterosalpingography was performed 2-5 days after
the end of menstruation, and analysis of the partner’s semen
was performed after 2-4 days of abstinence. Fertility is mostly
affected by ovulatory factors, uterine factors, endometriosis, male
factors, and unexplained subfertility. Ovulatory factors include
irregular menstrual cycles or anovulation. Uterine factors include
a uterine myoma larger than 6 cm or with distortion of the uterine
cavity, adenomyosis or endometrial polyp. Endometriosis was
diagnosed by ultrasound or laparoscopy. Male factors include at
least two semen analyses 4 weeks apart showing a sperm count
<15×106/ml or <40% motility or <4% strict normal morphology.
If no abnormal findings were found, they were classified as
unexplained subfertility.
Each cycle was individualized at the discretion of the
physician according to standard institutional protocols. In
couples with ovulatory factor, ovulation induction was initiated
from the first cycle. In couples with non-ovulatory causes, timed
intercourse was performed in natural cycle or ovulation
induction cycle. Ovulation induction was initiated with
clomiphene citrate (CC) or letrozole by the preference of
physician and couples. The gonadotropin was added if the
follicular growth was inadequate in the present or previous
cycle by the physician’s preference. Follicular growth was
monitored by TVUS from days 11-15 of the menstrual cycle
until the follicle reached 18-20 mm. When the diameter of at
least one follicle reached 18 mm, 5,000 IU of urinary human
chorionic gonadotropin (hCG) (IVF-C; LG Life Sciences,
Republic of Korea) or 250 mg of recombinant hCG (Ovidrel
liquid; Merck, Switzerland) was administered intramuscularly or
subcutaneously. The patients were advised to have intercourse
34-40 hours after hCG administration. If the dominant follicle
was confirmed but did not reach 18-20mm and further follow-up
was not possible, patients were advised to have intercourses for
three consecutive days when the follicle diameter is expected to
reach 20-24 mm. For the ovulation induction cycles, CC
(Clomiphene 50-150 mg/d; Young Poong Pharma, Seoul,
Republic of Korea) or letrozole (Femara 5 mg/day; Novartis,
Basel, Switzerland) was administered for 5 days starting from
menstrual cycle day 3 to 5. If necessary, 75 or 150 IU of
recombinant FSH (Follitrope, LG Life Sciences) or human
menopausal gonadotropin (IVF-M; LG Life Sciences) was
also administered.
As soon as the patients missed the next period, they
performed a self-administered urine pregnancy test. ClinicalFrontiers in Endocrinology | www.frontiersin.org 3pregnancy was defined as the presence of one or more
gestational sacs by transvaginal ultrasound at 3 to 4 weeks
after ovulation. Miscarriage was defined as fetal demise or the
absence of a fetal heart rate before 20 weeks. If pregnancy was not
achieved, the next cycle was started.
To compare the clinical characteristics and parameters
between the pregnant and non-pregnant groups or cycles, the
two-sample t-test was used for continuous variables and chi-
squared or Fisher’s exact test was used for categorical variables as
appropriate. Logistic regression analysis was performed to
determine significant variables that could independently
contribute to pregnancy. A value of p<0.05 was considered
statistically significant. The CPRs and CLBRs were analyzed
using McNemar’s test, and the significance level was corrected
using the Bonferroni method. The CPRs and CLBRs from groups
with different causes of subfertility were compared using
generalized estimating equation (GEE), and a value of p<0.05
was considered statistically significant. All statistical analyses
were conducted using IBM SPSS ver. 25.0 (IBM corp., Armonk,
NY, USA), SAS version 9.4 (SAS Institute, Cary, NC, USA) and R
package version 4.0.2 (http://www.R-project.org).RESULTS
The overall clinical pregnancy rate was 28.1% (80/285) per
couple and 9.4% (80/854) per cycle. The overall live birth rate
was 23.2% (66/285) per couple and 7.7% (66/854) per cycle. Ten
pregnancies resulted in miscarriages during the first trimester, 3
were ectopic (2.5%), and 1 was a stillbirth (1.25%). Of the 66 live
births, 5 were twin pregnancies (7.6%).
The clinical characteristics of the pregnant and non-pregnant
groups are shown in Table 1. The parity, number of cycles, basal
serum LH, E2, tubal patency, and semen parameters were
comparable between the groups. The pregnant group had a
younger age, higher body mass index (BMI), higher percentage
of irregular menstrual cycles, a shorter duration of subfertility,
lower serum FSH levels, and higher AMH levels than the non-
pregnant group. The causes of subfertility were significantly
different between the pregnant and non-pregnant groups.
Logistic regression analysis for predicting pregnancy is shown
in Table 2. In univariate analysis, female age ≥35 years, the
duration of subfertility, serum basal FSH levels and a longer
duration of subfertility (≥24 months) as well as unexplained
infertility, uterine factors, and endometriosis as a cause of
subfertility showed a lower probability to achieve conception.
In multivariate analysis, a longer duration of subfertility [≥24
months vs. <12 months; odds ratio (OR): 0.19; 95% confidence
interval (CI): 0.043-0.846; p=0.029] and endometriosis as a cause
of subfertility (vs. ovulatory factors; OR: 0.291; 95% CI: 0.110-
0.774; p=0.013) remained as independent unfavorable predictors
for clinical pregnancy. The participants were also stratified into
two groups according to the cause of subfertility (ovulatory
factor and non-ovulatory factor). Logistic regression analysis
for predicting pregnancy was conducted according to ovulatory
factor and non-ovulatory factor (Table 3). In univariate analysis,April 2021 | Volume 12 | Article 650883
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(≥24 months) showed a lower probability to achieve conception
of subfertile couples with ovulatory factor. In multivariate
analysis, female age ≥ 35 years (vs. ≥35 years; OR: 0.29; 95%
CI: 0.086-0.947; p=0.040) and duration of subfertility ≥ 24
months (vs. <24 months; OR: 0.193; 95% CI: 0.041-0.908;Frontiers in Endocrinology | www.frontiersin.org 4p=0.037) remained as independent unfavorable factors for
clinical pregnancy. Higher BMI ≥25 kg/m2 remained as
independent favorable factor (vs. <25 kg/m2; OR: 3.202; 95%
CI: 1.020-10.046; p=0.046). For subfertile couples with non-
ovulatory factors, a longer duration of subfertility ≥24 months
was an independent unfavorable predictor of clinical pregnancyTABLE 2 | Logistic regression analysis of the clinical characteristics to predict pregnancy in women undergoing timed coitus.
Variables Univariate p-value Multivariate p-value
OR (95% CI) OR (95% CI)
Age of women (years) 0.276
<35 1 1
≥35 0.558 (0.320-0.976) 0.041 0.715 (0.39-1.309)
Duration of subfertility (months) 0.079
<12 1 1
12-24 0.852 (0.451-1.61) 0.621 0.766 (0.399-1.472) 0.424
≥24 0.196 (0.045-0.859) 0.031 0.19 (0.043-0.846) 0.029
Causes of subfertility 0.062
Ovulatory 1 1
Unexplained 0.446 (0.231-0.861) 0.016 0.524 (0.265-1.036) 0.063
Uterine 0.470 (0.229-0.965) 0.040 0.529 (0.254-1.101) 0.089
Endometriosis 0.302 (0.116-0.791) 0.015 0.291 (0.110-0.774) 0.013
Male factor 0.216 (0.026-1.822) 0.159 0.307 (0.034-2.747) 0.291
Body mass index (kg/m2)
<25 1
≥25 1.775 (0.889-3.545) 0.104
Serum basal FSH (mIU/mL) 0.101
<10 1 1
>10 0.295 (0.101-0.866) 0.026 0.394 (0.13-1.2)April 2021 | Volume 12 | ArticleFSH, follicle-stimulating hormone.TABLE 1 | Comparison of the clinical characteristics between the pregnant and non-pregnant groups.
Variables Total (n=285) Pregnant group (n=80) Non-pregnant group (n=205) p-value
Age of women (years) 33.68 ± 3.69 32.88 ± 3.32 33.99 ± 3.79 0.045
Body mass index (kg/m2) 21.94 ± 3.67 22.57 ± 3.25 21.69 ± 3.82 0.008
Menstrual cycle 0.006
Regular 158 (55.4%) 34 (42.5%) 124 (60.5%)
Irregular 127 (44.6%) 46 (57.5%) 81 (39.5%)
Previous pregnancy 0.557
No 203 (71.2%) 59 (73.8%) 144 (70.2%)
Yes 82 (28.8%) 21 (26.3%) 61 (29.8%)
Duration of subfertility (months) 15.39 ± 19.36 11.33 ± 11.1 17.16 ± 21.58 0.003
Causes of subfertility 0.018
Ovulatory 103 (36.1%) 41 (51.25%) 62 (30.2%)
Unexplained 79 (27.7%) 18 (22.5%) 61 (29.8%)
Uterine 59 (17.54%) 14 (17.5%) 45 (22.0%)
Endometriosis 36 (12.6%) 6 (7.5%) 30 (14.6%)
Mild male factor 8 (2.8%) 1 (1.25%) 7 (3.4%)
Mean number of cycles 3.03 ± 2.33 2.8 ± 2.479 3.03 ± 2.267 0.47
Basal serum FSH (mIU/mL) 8.61 ± 7.94 7.14 ± 3.32 9.04 ± 8.71 0.008
Basal serum LH (mIU/mL) 7.34 ± 5.15 7.96 ± 4.76 7.10 ± 5.28 0.598
Basal serum E2 (pg/mL) 60.61 ± 62.92 62.11 ± 44 60.03 ± 68.91 0.915
AMH (ng/dL) 5.58 ± 5.33 7.11 ± 6.22 4.99 ± 4.67 0.008
Age of husband (years) 36.05 ± 4.86 35.75 ± 4.49 36.20 ± 5.05 0.381
Semen analysis
TMSC 105.39 ± 108.15 107.17 ± 127.73 105.07 ± 104.77 0.254
Motility (%) 51.10 ± 25.19 52.61 ± 22.53 50.83 ± 25.72 0.974
Strict morphology (%) 7.03 ± 14.46 6.42 ± 12.95 7.15 ± 14.77 0.649
Concentration (×106/ml) 58.10 ± 47.50 47.66 ± 34.85 60.05 ± 49.38 0.209Data are presented as the mean ± S.D., or number of cases (%).
FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2, estradiol; AMH, anti-Müllerian hormone; TMSC, total motile sperm count.650883
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(CI): 0.042-0.819; p=0.042) (Table 3).
No significant differences were observed in the cycle
characteristics, including ovulation induction regimen,
endometrial thickness, and pattern, and the number of follicles
with a diameter ≥14 mm, between the pregnant and non-
pregnant cycles (Table 4).
The estimated CPRs at 1, 3, 6, 9, and 12 cycle(s) were 9.8%,
22.5%, 26.7%, 27.0%, and 28.1%, respectively (Figure 1).
Comparing the difference in the CPR from the previous cycle
in each cycle, the CPR substantially increased during the first
three cycles and significantly increased until the fifth cycle. No
significant increase was found in the CPR after the sixth cycle. In
the sixth cycle, the maximal CPR was approached, and no
significant difference was observed between the maximal CPR
and CPR of the additional cycles. The estimated CLBRs at 1,3,6,
and 12 cycle(s) were 7.7%, 19.0%, 22.1%, 23.2%, respectively
(Figure 1). The CLBRs also substantially increased during the
first three cycles. There was a significant increase until the fourth
cycle but no significant difference after the fifth cycle. TheFrontiers in Endocrinology | www.frontiersin.org 5estimated CPRs (Figure 2A) and CLBRs (Figure 2B) in each
group of ovulatory factor, uterine factor, endometriosis factor
and unexplained factor which is combined with mild male factor
showed similar trends to overall results. The CPRs and CLBRs of
the ovulatory factor were the highest, and those of endometriosis
was the lowest. The CPRs were statistically different (p = 0.0102)
and CLBRs were different with borderline significance among
these groups (p=0.0591).DISCUSSION
In this single-center retrospective cohort study, 854 cycles in 285
patients were analyzed to determine predictive factors for
pregnancy and evaluate the CPR and the CLBR in couples
undergoing TI with ultrasound. The causes of subfertility and
duration of subfertility were independent predictors for
pregnancy during TI with ultrasound. Age and BMI were also
independent predictive factors for pregnancy in subfertile
couples with ovulatory factors. Both the CPRs and the CLBRsTABLE 3 | Logistic regression analysis of the clinical characteristics to predict pregnancy in timed intercourse of subfertile couples with ovulatory factor and non-
ovulatory factor.
Variables Ovulatory factor Non-ovulatory factor
Univariate Multivariate Univariate Multivariate
OR(95% CI) p-value OR(95% CI) p-value OR(95% CI) p-value OR(95% CI) p-value
Age of women
(years)
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pregnant patients conceived. The CPRs significantly increased
until the fifth cycle but did not after the sixth cycle. The CLBRs
significantly increased until the fourth cycle but did not after the
fifth cycle. To our best knowledge, few studies have reported on
the pregnancy outcomes of TI with ultrasound (31).
Many couples who have visited the clinic for subfertility care
believe that they are already having targeted sexual intercourse
through multiple information sources. However, only 13% of
them correctly identified the fertile window (32). A study using
data from the anonymous information stored in the cloud
database from users of the Clearblue® Connected Ovulation
Test System (SPD Swiss Precision Diagnostics, GmbH, Geneva,
Switzerland) showed that ovulation days could vary widely, even
if the cycle length can be predicted with this system (33). In
addition, it has been suggested that effective fertile windows are
narrower in many subfertile couples (34, 35). Therefore, it is
important to provide the exact ferti l ity window to
subfertile couples.
TI with ultrasound is a direct method to precisely predict the
fertile window. However, there may be several disadvantages.
Although the risk of subjective interpretations of the ultrasonic
morphology of the ovaries is possible (29), bias by the physician
might be minimal because our study was performed by an
experienced infertility specialist. Ultrasound is relatively
expensive and less accessible. However, these additional costs
and efforts are counterbalanced by the potential to prevent
overtreatment such as ART in couples who could conceive
with TI (36). In addition, the cost of ultrasound is cheaper
than that in other countries and is partially covered by national
health insurance in Korea. TI with ultrasound has been widely
used for subfertile couples with patent fallopian tubes and
adequate semen parameters in Korea.Frontiers in Endocrinology | www.frontiersin.org 6TI with ovulation induction is an effective treatment for
women with ovulatory factors (36, 37). Women with higher
AMH and/or irregular menstrual cycles had a better chance of
pregnancy, and these characteristics were frequently shown in
women with ovulatory factors. In the present study, the CPR was
the highest at 39.8% and the CLBR was also higher with
borderline statistical significance at 28.2% in subfertile couples
with ovulatory factors when compared to subfertile couples with
other causes. Old age and longer duration of subfertility were
unfavorable independent predictors for pregnancy and higher
BMI was a favorable independent predictor.
Although it is not clear that women with endometriosis may
benefit from ovulation induction, it has been empirically used for
subfertile women without absolute causes of infertility. There are
several treatment options available to women with endometriosis
who are seeking fertility. While not routinely recommended,
expectant management is an option for women who are hesitant
to pursue ovarian stimulation with or without IUI or in vitro
fertilization (IVF). The fecundity rate of women with
endometriosis is lower than non-infertile reproductive
population. However, women with endometriosis can conceive
without intervention. After surgical treatment, the choice
between expectant management, empirical treatment, and IVF
should be based on age, surgical results, and the severity of any
other coexisting infertility factors. Treatment options for
asymptomatic women with known or suspected minimal or
mild endometriosis and no other infertility factors include
expectant management, surgical treatment, empirical
treatment, clomiphene or exogenous gonadotropins and IUI,
and IVF (38, 39). If, therefore, women with endometriosis are
eligible for timed coitus with ultrasound, they were included in
the present study. In the present study, 30 of 36 patients with
endometriosis were included after surgical treatment. AlthoughTABLE 4 | Comparison of the cycle characteristics between the pregnant and non-pregnant cycles.
Variables Total Pregnant cycles Non-pregnant cycles p-value
Cycle Number 854 80 (9.4%) 774 (90.6%)
Regimen 0.629
Natural cycle 131 (15.3%) 10 (12.5%) 121 (15.6%)
CC 281 (32.9%) 27 (33.75%) 254 (32.8%)
Letrozole 372 (43.6%) 36 (45%) 336 (43.4%)
CC + gonadotropin 28 (3.3%) 1 (1.25%) 27 (3.5%)
Letrozole + gonadotropin 42 (4.9%) 6 (7.5%) 36 (4.7%)
hCG injection 0.133
No 554 (64.9%) 58 (72.5%) 496 (64.1%)
Yes 300 (35.1%) 22 (27.5%) 278 (35.9%)
EM pattern 0.252
non-triple 99 (11.7%) 6 (7.7%) 93 (12.1%)
triple 750 (88.3%) 72 (92.3%) 678 (87.9%)
EM polyp 0.240
yes 132 (15.5%) 16 (20%) 116 (15%)
no 721 (84.5%) 64 (80%) 657 (85%)
EM thickness (mm) 0.37
<7 mm 103 (12.1%) 7 (9%) 96 (12.5%)
≥7 mm 746 (87.9%) 71 (91%) 675 (87.5%)
Number of follicles
≥14 mm 1.60 ± 1.08 1.65 ± 0.978 1.6 ± 1.087 0.447April 2021 | Volume 12 | ArticleData are presented as the mean ± S.D., or number of cases (%).
CC, clomiphene citrate; hCG, human chorionic gonadotropin; EM, endometrium.650883
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improved the chance of natural conception (40, 41), women
with endometriosis had a significantly lower pregnancy rate than
women with ovulatory factors. The CPR at 10months was
significantly the lowest at 16.7% and the CLBR was also lower
with borderline statistical significance at 13.9%. Our findings
were in line with the results from the previous study (42). Few
studies have compared the effects of TI according to infertility
causes, but a study that assessed the pregnancy rate of those on
the IVF waiting list showed interesting results (43). Women with
endometriosis had the lowest hazard ratio to have a treatment-
free ongoing pregnancy, indicating they will have the least
effectiveness using non-ART strategies. The women with
endometriosis should consider advancing earlier to the next
treatment such as ART. Uterine factors including a uterine
myoma larger than 6 cm or with distortion of the uterine
cavity, adenomyosis, and endometrial polyp have been
implicated in infertility. However, the clinical evidence and
benefit of different management options for subfertility are alsoFrontiers in Endocrinology | www.frontiersin.org 7conflicting (44–46). TI with ovulation induction has been
empirically used for subfertile women with normal ovulatory
function including unexplained infertility, although it is not
recommended as it is no more effective than expectant
management (47). Our findings of CPRs and CLBRs may
provide data on subfertility management for subfertile couples
with nonovulatory factors in real–world setting.
The duration of subfertility has been used as a major factor to
start infertility treatment. Several studies showed that the
pregnancy rate was particularly compromised by the duration
of subfertility in TI (31, 42, 48–50), a finding that agrees with our
findings. Our study was similar to a prospective cohort study of
couples with at least 1 year of unsuccessful attempts to conceive
who undergo TI after FABM training. A duration of non-
conception for more than 2 years significantly reduces the
chances of pregnancy (p=0.006; OR: 0.38; 95% CI: 0.19-0.97)
(42). In a randomized controlled trial using 2 cycles of TI and
fertility awareness device measurement of the E1G and LH levels,
more women who had been trying to conceive for <6 monthsFIGURE 1 | Estimated cumulative pregnancy and live birth rates per cycle and trend. CPR, Cumulative pregnancy rate; CLBR, Cumulative live birth rate.
aMcNemar’s test: comparing the cumulative pregnancy rate in each cycle with the cumulative pregnancy rate in the previous cycle. bMcNemar’s test: comparing the
cumulative total cumulative pregnancy rates and pregnancy rate in each cycle. *The significance level corrected by Bonferroni method is 0.05/11 = 0.0045.April 2021 | Volume 12 | Article 650883
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(OR: 2.67) (48). In the present study, couples with subfertility
duration ≥24 months had a poor prognosis and the longer
duration of subfertility was found to be an independent
unfavorable factor in both couples with ovulatory factor and
non-ovulatory factors. However, no significant difference was
found in the pregnancy rates between the groups with a duration
<12 months and those with a duration between 12 and 24
months. The cause may be due to the difference in the study
participants. The present study included couples with subfertility
duration >6 months, but the previous study included volunteers
with favorable outcomes. Therefore, our findings suggest that TI
with ultrasound for couples with a subfertility duration of less
than 2 years may still be considered if they have no absolute
indication for ART.
It is well recognized that fertility declines as age increases. In the
present study, however, female age >35 years was not an
independent factor to predict pregnancy in the multivariate
logistic regression model. Logistic regression analysis for
predicting pregnancy shows all age categories (37, 38, 39 and 40
years of age as a cutoff age) were not independent unfavorableFrontiers in Endocrinology | www.frontiersin.org 8predictors for clinical pregnancy in overall participants. Participants
were subdivided into subfertile couples with ovulatory factor and
non-ovulatory factors and logistic regression analyses were
performed in each group. Age was the independent unfavorable
predictor for clinical pregnancy in subfertile couples with ovulatory
factor but still not in subfertile couples with non-ovulatory factors.
Since, although it was clearly explained, the present study included
subfertile couples with heterogeneous etiologies including uterine
factor, endometriosis, and mild male factor, this finding may be
attributed to the selection bias.
Cycle characteristics have been implicated in the success
of ART (51, 52). However, cycle characteristics, including
endometrial pattern and thickness, the presence of endometrial
polyps, the number of follicles >14 or 18 mm, and whether hCG
was administered did not affect pregnancy in the present study.
Additionally, ovulation methods did not affect pregnancy.
ART is often regarded as a panacea and first-line treatment
for those with difficulty in achieving pregnancy as they developed
dramatically. There is no evidence-based guideline on the
reasonable and sustainable duration of TI. Reliable estimates of
cumulative probabilities are important in identifying appropriateA
B
FIGURE 2 | Estimated cumulative pregnancy rate (A) and live birth rate (B) per each cycle and trends according to subfertile causes. CPR, Cumulative pregnancy
rate; CLBR, Cumulative live birth rate. *Eight cases of the mild male factor data were combined with the unexplained factor group. **Generalized estimating equation.April 2021 | Volume 12 | Article 650883
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of treatment.
Most studies of timed intercourse focused on ovulation
prediction methods were conducted on women without known
infertility, (53) or with a short period of trying to conceive (48).
The effect of timed intercourse in fertile couples and subfertile
couples is assumed to be different. The previous study showed
that the quality of FABM like the vaginal discharge correlates
well with the cycle-specific probability of pregnancy in normally
fertile couples but less in subfertile couples (54). Approximately
85-90% of healthy young couples conceive within 1year, most
within 6 months (1, 2). The present study included couples with
sufficient duration for more than 6 months. Therefore,
participants in the present study may have decreased
reproductive efficiency. Timed intercourse using various
ovulation prediction methods may be a reasonable
recommendation for those couples. Although timed
intercourse has been widely used for those couples in the daily
fertility practice, data on predictive factors and cumulative
pregnancy or live birth rate were still lacking, especially in
timed intercourse using ultrasound. Our findings may provide
the effectiveness on timed intercourse in subfertile couples
without absolute infertile causes, such as bilateral tubal
obstruction and premature menopause.
In the present study, the estimated CPRs at one, three, six, nine,
and 12 cycle(s) were 9.8%, 22.5%, 26.7%, 27.0%, and 28.1%,
respectively. Studies have estimated the CPR with TI using
various methods under different settings. In a randomized
controlled trial using urinary LH and the E1G kit, the CPR for
two cycles was 22.7% (48). This study has limitations in that only 2
cycles were conducted and participants were excluded if they had
been trying to conceive for > 2 years; the median time trying to
conceive was short, only 8 months. Koo et al. (31) compared the
likelihood of achieving pregnancy using TI with ultrasound
according to the serum AMH levels. The clinical pregnancy rate
of 202 women was 40.6% with up to 29 months of follow-up. The
CLBRs differed according to the serum AMH level compared with
4.0%-26.0% at 6 months, 4.0%-37.7% at 12 months, and 17.2%-
41.8% at 18 months. No results were obtained for the CPR at each
cycle and for the CLBR of all the participants, limiting the ability to
compare their findings with ours. However, a relatively high CPR
and CLBR may be due to the favorable characteristics of the
participants because women with other causes of subfertility, such
as uterine factors, endometriosis, irregular menstruation, and
polycystic ovary syndrome (PCOS), were excluded.
The Irish retrospective cohort study of 1,072 women undergoing
TI with FABM found similar results to ours, with a CPR at 1 year of
25.9% (55). However, the CPR at 6 months was lower than ours at
14.1%, and long-term follow-up of up to 24months presented a CPR
of 33%. The study provided additional treatments, such as those to
support luteal hormonal production and medication to enhance
cervical mucus production. By comparison, a German prospective
cohort study with 340 women undergoing TI with FABM
demonstrated higher estimated CPRs of 38%, 68%, 81%, and 92%
at one, three, six, and 12 cycles, respectively (2). The participants
switched immediately from contraception to reproduction using TI;Frontiers in Endocrinology | www.frontiersin.org 9therefore, the first cycle using TI was also their first attempt for
pregnancy. However, the average duration of time spent previously
trying to pregnancy for the Irish study population was 5.6 years,
which is greater than that of our study. These characteristics may be
a major factor associated with the difference in CPR in each study. In
the earlier studies, as the number of TI cycles increased, the rate of
increase in the CPR tended to decrease. In a study conducted on TI
based on the method of calendar calculations, the maximal
pregnancy rate was approximately 30% per cycle in the first two
cycles and then progressively decreased (56). In an observational
study, the estimated CPR was analyzed for 340 women who had
undergone TI with FABM. Most pregnancies occurred within six
cycles (2), and other studies also suggest at least six cycles before any
intervention (57, 58). In the present study, the CPR and the CLBR
substantially increased during the first three cycles and 80% of
pregnant patients conceived. The CPR and the CLBR also
significantly increased until the fifth and fourth cycle, respectively,
which may be considered as valid findings that was not statistically
disclosed in other studies. Our findings suggest that three cycles of TI
are highly recommended and that performing only up to six cycles is
likely appropriate because the pregnancy rate does not increase
significantly after the sixth cycle.
The present study has several limitations. First, more than half
of the patients (58.2%; 166/285) withdrew from treatment before
six cycles of treatment. After the 9th cycle, the number of patients
was very small in each cycle. Because TI is a conservative or
initiating treatment in practice, dropout is difficult to avoid in
long-term follow-up studies like ours due to the tendency to
advance to the next-step treatment. Many patients were dropped
out for various reasons including pregnancy, starting advanced
infertility treatment, and loss of follow-up. Several previous studies
did not report the dropout rate, while others have reported 55%
for up to five cycles (59) and 64% (60) for up to six cycles in cohort
studies of ART. Therefore, the dropout rate from our study is
comparable to that from previous studies. Second, heterogeneity in
subfertile causes could be a major limitation of the present study.
Since, however, many infertile couples suffer from multiple
etiologies, data on subfertile couples with homogenous cause
may not provide sufficient information to those couples.
Therefore, the present study may provide the information on
the effectiveness of timed intercourse of subfertile couples in real-
world setting. Third, the present study had not control or
comparator group. Since the aim of this study was to determine
predictive factors for pregnancy and assess the CPR in subfertile
couples undergoing TI with ultrasound, the outcomes between TI
using ultrasound monitoring were not compared with those using
other methods or no treatment. In the previous study, cycle
fecundability was 4.9%(55 pregnancies/1123 cycles) when
subfertile couples conducted the fertility awareness training
through tracking basal body temperature and cervical secretions
(42). Also untreated patients with unexplained infertility have a
cycle fecundability ranging typically between 2% and 4% (61). In
fact, our study could have different patient characteristics from
those of previous studies, which makes it difficult to directly
compare cycle fecundability with those of previous studies.
Considering, however, that the cycle fecundability was 9.4% inApril 2021 | Volume 12 | Article 650883
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option for subfertile patients. Fourth, insufficient power was the
limitation of the present study. A power calculation was
performed using PAWE (Power for Association with Error)
software version 1. 2. (http://linkage.rockefeller.edu/pawe/pawe.
cgi). A total of 406 patients (114 in pregnant group and 292 in
non-pregnant group) would be needed to detect a 6-month
difference in the duration of infertility between pregnant and
non-pregnant group with a significance level of 0.05 and 80%
power when the pregnancy rate was assumed to be 25%. Our
sample size has the power of 66% to detect a significant difference
for the duration of infertility. To our best knowledge, however, few
studies have reported on the pregnancy outcomes of TI with
ultrasound. Moreover, there has been no randomized trial in this
issue. In spite of several weaknesses of the present study, therefore,
our study might provide meaningful findings in a real-world
setting for subfertile patients eligible for timed coitus. In the
future, additional randomized controlled trials on a larger scale
would be necessary to confirm our findings.
In conclusion, we found that the duration of non-pregnancy
for more than 2 years and endometriosis reduced the chances of
pregnancy during TI with ultrasound. In subfertile women with
ovulatory factors, old age ≥35 years may be an unfavorable
predictor of pregnancy and higher BMI ≥ 25 kg/m2 may be a
favorable predictor during TI with ovulation induction using
ultrasound monitoring. TI with ultrasound of three cycles was an
acceptable option for subfertile couples without absolute
indication of ART. However, couples who failed to achieve
conception by the fourth or fifth cycle of TI with ultrasound
may be encouraged to consider advancing to the next treatment
strategy. This study provided useful information on predictive
factors of conception, CPR and CLBR in subferile couples
undergoing TI with ultrasound. Physicians should provide
individualized approaches to patients with further refinement
based on the number of treatments to avoid over- and under-
treatment. In future work, large prospective control studies are
needed to confirm these findings.Frontiers in Endocrinology | www.frontiersin.org 10DATA AVAILABILITY STATEMENT
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